✦ LIBER ✦

Neurofilament proteins NF-L, NF-M and NF-H in brain of patients with Down syndrome and Alzheimer's disease

✍ Scribed by M. Bajo; B. C. Yoo; N. Cairns; M. Gratzer; G. Lubec

Publisher: Springer
Year: 2001
Tongue: English
Weight: 57 KB
Volume: 21
Category: Article
ISSN: 0939-4451
DOI: 10.1007/s007260170015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Decreased levels of synaptosomal associa

Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down Syndrome and Alzheimer's disease

✍ Susi Greber; Gert Lubec; Nigel Cairns; Michael Fountoulakis 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 2 views

Vitamin E concentrations in human brain

Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls

✍ T. Metcalfe; D. M. Bowen; D. P. R. Muller 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 409 KB

Changes of voltage-dependent anion-selec

Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down Syndrome

✍ Byong Chul Yoo; Michael Fountoulakis; Nigel Cairns; Gert Lubec 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 556 KB

Voltage-dependent anion-selective channel proteins (VDACs) are pore-forming proteins found in the other mitochondrial membrane of all eukaryotes and in brain postsynaptic membranes. VDACs regulate anion fluxes of a series of metabolites including ATP, thus regulating mitochondrial metabolic function

Decreased levels of complex III core pro

Decreased levels of complex III core protein 1 and complex V β chain in brains from patients with Alzheimer’s disease and Down syndrome

✍ S. H. Kim; R. Vlkolinsky; N. Cairns; G. Lubec * 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 153 KB

Season of birth: dementia in Alzheimer's

Season of birth: dementia in Alzheimer's disease in adults with Down Syndrome

✍ V. P. Prasher; H. M. Kapadia; M. S. Haque 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

A 24-week, double-blind, placebo-control

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease—pilot study

✍ Vee. P. Prasher; Adam Huxley; M. S. Haque 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Abstract ## Background Donepezil Hydrochloride (Aricept) is a selective anticholinesterase inhibitor developed for the treatment of Alzheimer's disease (AD). This study investigated the safety and efficacy of the drug to treat Down syndrome (DS) adults with mild to moderate AD. ## Method This